Our Cardiac Arrhythmia Research Program is located at the Washington Heart and Vascular Institute at MedStar Washington Hospital Center. Our investigators are electrophysiologists who belong to one of the largest electrophysiology (EP) clinical labs in the country, conducting more than 4,500 procedures annually, using advanced diagnostic tools. This clinical activity gives rise to a significant pool of potential participants for clinical trials. Some of our lines of research include:
- Comparing the implant success and complication rates for cardiac leads and catheters
- Determining if an implantable cardioverter defibrillator (ICD) will improve survival in people with coronary artery disease (CAD)
- Comparing two different drugs determine the safety and effectiveness of each in preventing strokes in patients with Atrial Fibrillation
- You were selected as a possible participant in this study because your physician has determined you are to receive or have already received cardiac leads, pacemaker, defibrillator or resynchronization therapy device. The data collected from this study will be used to evaluating the clinical experience of patients with cardiac leads, pacemakers, defibrillators, or resynchronization therapy devices to provide early notification about potential lead performance problems and their management.
- Determining the genetic factors that make some people more likely than others to have life-threatening heart rhythms in order to recommend treatment for patients at highest risk for sudden cardiac death in the future